Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.

Combined chemoradiation for head and neck region myxofibrosarcoma of the maxillary sinus.

Cante D, Franco P, Sciacero P, Girelli GF, Casanova Borca V, Pasquino M, Tofani S, Bombaci S, Migliaccio F, Marra A, Numico G, La Porta MR, Ricardi U.

Tumori. 2013 Mar-Apr;99(2):e80-3. doi: 10.1700/1283.14214.

PMID:
23748836
2.

Intensity-modulated radiation therapy with simultaneous integrated boost in unresected left-sided pleural mesothelioma: a case report.

Cilla S, Digesú C, Silvano G, Macchia G, Massaccesi M, Deodato F, Padula GD, Fidanzio A, Piermattei A, Morganti AG.

Tumori. 2010 Jul-Aug;96(4):618-22.

3.

Phase 2 trial of concurrent 5-fluorouracil, hydroxyurea, cetuximab, and hyperfractionated intensity-modulated radiation therapy for locally advanced head and neck cancer.

Kao J, Genden EM, Gupta V, Policarpio EL, Burri RJ, Rivera M, Gurudutt V, Som PM, Teng M, Packer SH.

Cancer. 2011 Jan 15;117(2):318-26. doi: 10.1002/cncr.25374.

4.

Concurrent platinum-based chemotherapy and hyperfractionated radiotherapy with late intensification in advanced head and neck cancer.

Glicksman AS, Wanebo HJ, Slotman G, Liu L, Landmann C, Clark J, Zhu TC, Lohri A, Probst R.

Int J Radiat Oncol Biol Phys. 1997 Oct 1;39(3):721-9.

PMID:
9336155
5.

Phase I/II study of docetaxel, cisplatin, and concomitant boost radiation for locally advanced squamous cell cancer of the head and neck.

Tsao AS, Garden AS, Kies MS, Morrison W, Feng L, Lee JJ, Khuri F, Zinner R, Myers J, Papadimitrakopoulou V, Lewin J, Clayman GL, Ang KK, Glisson BS.

J Clin Oncol. 2006 Sep 1;24(25):4163-9.

PMID:
16943532
6.

Evaluation of spatially fractionated radiotherapy (GRID) and definitive chemoradiotherapy with curative intent for locally advanced squamous cell carcinoma of the head and neck: initial response rates and toxicity.

Peñagarícano JA, Moros EG, Ratanatharathorn V, Yan Y, Corry P.

Int J Radiat Oncol Biol Phys. 2010 Apr;76(5):1369-75. doi: 10.1016/j.ijrobp.2009.03.030.

PMID:
19625138
7.

Preoperative cisplatin and accelerated hyperfractionated radiation induces high tumor response and control rates in patients with advanced head and neck cancer.

Wanebo HJ, Glicksman AS, Landman C, Slotman G, Doolittle C, Clark J, Koness RJ.

Am J Surg. 1995 Nov;170(5):512-6.

PMID:
7485745
8.

A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer.

Guerrero Urbano T, Clark CH, Hansen VN, Adams EJ, A'Hern R, Miles EA, McNair H, Bidmead M, Warrington AP, Dearnaley DP, Harrington KJ, Nutting CM.

Radiother Oncol. 2007 Oct;85(1):36-41.

PMID:
17709149
9.

IMRT using simultaneously integrated boost (SIB) in head and neck cancer patients.

Studer G, Huguenin PU, Davis JB, Kunz G, Lütolf UM, Glanzmann C.

Radiat Oncol. 2006 Mar 31;1:7.

10.

Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up.

Rapidis AD, Trichas M, Stavrinidis E, Roupakia A, Ioannidou G, Kritselis G, Liossi P, Giannakouras G, Douzinas EE, Katsilieris I.

Oral Oncol. 2006 Aug;42(7):675-84.

PMID:
16731029
11.

Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy.

Butler EB, Teh BS, Grant WH 3rd, Uhl BM, Kuppersmith RB, Chiu JK, Donovan DT, Woo SY.

Int J Radiat Oncol Biol Phys. 1999 Aug 1;45(1):21-32.

PMID:
10477002
12.
13.

Leptomeningeal metastasis from prostate cancer.

Cante D, Franco P, Sciacero P, Girelli G, Casanova Borca V, Pasquino M, Migliaccio F, Tofani S, Grassi L, Marra A, Ozzello F, La Porta MR, Ricardi U.

Tumori. 2013 Jan-Feb;99(1):6e-10e. doi: 10.1700/1248.13803.

PMID:
23549020
14.

Six-week induction chemotherapy followed by concomitant chemoradiation therapy in stage IV head and neck cancer: a phase II study with organ-sparing purposes.

Mantovani G, Massa E, Astara G, Murgia V, Gramignano G, Ferreli L, Camboni P, Lusso MR, Mocci M, Madeddu C, Mura L, Mudu MC, Proto E, Tore G, Mura M, Macciò A, Ferreli A, Amichetti M.

Oncol Rep. 2003 May-Jun;10(3):759-66.

PMID:
12684655
15.

Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck.

Merlano M, Benasso M, Corvò R, Rosso R, Vitale V, Blengio F, Numico G, Margarino G, Bonelli L, Santi L.

J Natl Cancer Inst. 1996 May 1;88(9):583-9.

PMID:
8609658
16.

The role of surgery and radiotherapy in treatment of soft tissue sarcomas of the head and neck region: review of 30 cases.

Fayda M, Aksu G, Yaman Agaoglu F, Karadeniz A, Darendeliler E, Altun M, Hafiz G.

J Craniomaxillofac Surg. 2009 Jan;37(1):42-8. doi: 10.1016/j.jcms.2008.07.007.

PMID:
18804382
17.

[Radiotherapy plus a combination of cisplatin and 5-fluorouracil for locally advanced head and neck neoplasms. Study of feasibility and preliminary results].

Colombo A, Crispino S, Tancini G, Personeni A, Taino R, Sarti E, Barni S, Lissoni P, Placa F, Mazzola P, et al.

Radiol Med. 1990 Nov;80(5):713-8. Italian.

PMID:
2267392
18.

Gemcitabine, cisplatin, and radiation in advanced, unresectable squamous cell carcinoma of the head and neck: a feasibility study.

Benasso M, Merlano M, Sanguineti G, Corvò R, Numico G, Ricci I, Pallestrini E, Santelli A, Vitale V, Marchetti G, Rosso R.

Am J Clin Oncol. 2001 Dec;24(6):618-22.

PMID:
11801767
19.

Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions.

Milano MT, Vokes EE, Kao J, Jackson W, List MA, Stenson KM, Witt ME, Dekker A, MacCracken E, Garofalo MC, Chmura SJ, Weichselbaum RR, Haraf DJ.

Int J Oncol. 2006 May;28(5):1141-51.

PMID:
16596230
20.

Gemcitabine-based induction chemotherapy and concurrent with radiation in advanced head and neck cancer.

El Deen DA, Toson EA, El Morsy SM.

Med Oncol. 2012 Dec;29(5):3367-73. doi: 10.1007/s12032-012-0269-x.

PMID:
22678924

Supplemental Content

Support Center